Mounjaro™ (tirzepatide) – New drug approval
May 13, 2022 - The FDA announced the approval of Eli Lilly’s Mounjaro (tirzepatide), as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM).
Download PDF
